1. Home
  2. EXPI vs IMCR Comparison

EXPI vs IMCR Comparison

Compare EXPI & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$8.66

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$31.98

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
IMCR
Founded
2008
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EXPI
IMCR
Price
$8.66
$31.98
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$12.00
$64.30
AVG Volume (30 Days)
868.1K
550.4K
Earning Date
02-24-2026
02-25-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,678,653,000.00
$379,590,000.00
Revenue This Year
$6.03
$32.49
Revenue Next Year
$5.37
$11.05
P/E Ratio
N/A
N/A
Revenue Growth
5.12
28.11
52 Week Low
$6.90
$23.15
52 Week High
$12.23
$40.72

Technical Indicators

Market Signals
Indicator
EXPI
IMCR
Relative Strength Index (RSI) 28.28 35.90
Support Level $8.28 $30.60
Resistance Level $9.14 $33.49
Average True Range (ATR) 0.29 1.51
MACD -0.05 -0.23
Stochastic Oscillator 8.87 14.02

Price Performance

Historical Comparison
EXPI
IMCR

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: